The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence

IF 0.1 Q4 MEDICINE, GENERAL & INTERNAL
N. Avramenko, O. Kabachenko, D. Y. Barkovskyi, К. Sierykh
{"title":"The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence","authors":"N. Avramenko, O. Kabachenko, D. Y. Barkovskyi, К. Sierykh","doi":"10.14739/2310-1210.2023.3.251479","DOIUrl":null,"url":null,"abstract":"The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary-dependent pathology. One of the major consequences of weight problems is metabolic syndrome (MS).\nThere are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension).\nObesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome typical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia).\nFirst-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.","PeriodicalId":23832,"journal":{"name":"Zaporozhye Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zaporozhye Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14739/2310-1210.2023.3.251479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary-dependent pathology. One of the major consequences of weight problems is metabolic syndrome (MS). There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension). Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome typical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia). First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
代谢综合征在青春期多囊卵巢综合征发展中的作用
本文根据最新的国际指南和现代文献,综述了儿童和青少年代谢综合征问题及其在多囊卵巢综合征(PCOS)发展中的作用。问题的紧迫性在于超重在世界儿童中迅速蔓延,从而导致了食物依赖病理的增长。体重问题的主要后果之一是代谢综合征(MS)。目前还没有明确的儿童和青少年多发性硬化症标准。IDF建议对成人使用IDF标准。多发性硬化症的发病机制优先考虑胰岛素抵抗(IR),这与青春期有关。IR评估的问题仍然存在。HOMA-IR和QUICKI方法不被认为是确定IR的可靠方法,因此评估是基于临床症状(高血糖、血脂异常、腹部肥胖、高血压)。肥胖和IR可能是多囊卵巢综合征的预测因子,多囊卵巢综合征通常与青春期有关。青春期成人典型综合征的病理体征可能是青春期生理过程的一种表现。青春期PCOS的强制性诊断标准是月经不调/月经少,经生化证实和临床高雄激素血症)。多发性硬化症青少年多囊卵巢综合征的一线治疗方法是减肥和大剂量运动,这有助于使激素平衡正常化。药物治疗可能包括胰岛素增敏药物(二甲双胍)、抗雄激素(螺内酯、氟他胺、醋酸环丙孕酮)、5- α -还原酶抑制剂(非那雄胺)、联合口服避孕药、肌醇。预防儿童超重、肥胖可以预防IR的发展,从而预防相关的多发性硬化症和多囊卵巢综合征以及生殖健康障碍。预防措施的目的是避免产妇肥胖、妊娠期糖尿病、营养不良和怀孕期间吸烟,促进母乳喂养和体育活动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Zaporozhye Medical Journal
Zaporozhye Medical Journal MEDICINE, GENERAL & INTERNAL-
自引率
0.00%
发文量
72
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信